Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.2M Sell
8,420
-2,875
-25% -$785K 0.01% 1047
2026
Q1
$1.82M Buy
11,295
+3,790
+50% +$626K 0.01% 1139
2025
Q4
$823K Sell
7,505
-205
-3% -$17.4K ﹤0.01% 1320
2025
Q3
$383K Buy
+7,710
New +$376K ﹤0.01% 1443
2021
Q4
Sell
-1,509
Closed -$202K 1244
2021
Q3
$202K Sell
1,509
-1,096
-42% -$131K 0.01% 970
2021
Q2
$275K Buy
+2,605
New +$232K 0.01% 868
2019
Q3
Sell
-6,493
Closed -$202K 1226
2019
Q2
$202K Buy
+6,493
New +$209K ﹤0.01% 1069
2019
Q1
Sell
-11,559
Closed -$437K 1241
2018
Q4
$437K Buy
+11,559
New +$422K 0.01% 790

Other funds holding VICR

Joel Greenblatt's VICR Position: Q2 2026 in Review

Joel Greenblatt reduced its Vicor (VICR) stake by 25% in Q2 2026, selling an estimated $785K and leaving 8,420 shares worth $3.2M. The position accounts for 0.01% of the portfolio, ranked #1047.

Joel Greenblatt first reported a position in VICR in Q4 2018 and has held it in 8 quarters since. 512 funds tracked by Wall St. Rank hold VICR as of Q2 2026.

  • Joel Greenblatt held 8,420 shares of Vicor worth $3.2M as of Q2 2026.
  • Joel Greenblatt sold 2,875 Vicor shares in Q2 2026, an estimated $785K.
  • Vicor made up 0.01% of Joel Greenblatt's portfolio in Q2 2026, its #1047 holding.
  • Joel Greenblatt first reported a position in Vicor in Q4 2018 and has held it in 8 quarters since.
  • 512 funds tracked by Wall St. Rank held Vicor as of Q2 2026.

Based on Gotham Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.